Civitas Therapeutics
LATEST NEWS
Civitas Therapeutics Files Registration Statement for Proposed Initial Public Offering
RECENT NEWS
Civitas Therapeutics Secures $55 Million in Series C Financing
© 2014 CIVITAS THERAPEUTICS|190 EVERETT AVENUE, CHELSEA MA 02150|MAIN 617.660.4110|FAX 617.884.3990